AARDEX Group

digital therapeutics

Data Science and Medication Adherence

Examining the Role of Data Science in Understanding Patient Behaviors.

Our latest article in Applied Clinical Trials Online discusses the Role of Data Science and Understanding Patient Behavior. … Read More

AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence … Read More

Our latest article in PMPS discusses how non-adherence to medication has been costing lives and money for decades but SmartPackaging solutions are now solving the age-old problem.

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2021, pages 46-49. © Samedan Ltd

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence

AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence … Read More

A Digital Innovation for the Personalized Management of Adherence

Bernard Vrijens our CEO and Scientific Lead, and Anna-Elisa Hein realizing a master thesis placement at AARDEX Group, conducted a study analyzing the strengths, weaknesses, threats, and opportunities of digital innovation for the personalized management of medication adherence. Anna-Elisa interviewed … Read More

We see an uptake in Remote, Decentralized and Hybrid Trials. Do you?

We are soon leaving a very difficult year in all aspects. We lived with global pandemic and civil troubles in the news all year long. However, our Scientific Lead, Bernard Vrijens sees an uptake in remote, decentralized, and hybrid trials. … Read More

ONdrugDelivery October Issue is now live which includes a contribution of AARDEX Group

AARDEX’s Scientific Lead Bernard Vrijens and Biocorp’s business development director Arnaud Guillet give some details about their companies alliance. They explain how Biocorp’s Injay connected prefilled syringe (PFS) combined with AARDEX’s MEMS Adherence Software provides a mean to tackle the … Read More

The Contract Pharma October Issue is now live which includes an article about AARDEX Group

Medication adherence, which involves patients taking medications in accordance with how they have been prescribed, is a widespread challenge, with wide-reaching implications for patients and health services worldwide. Managing patient compliance can make the difference between failed and successful clinical … Read More

AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence

AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devices. … Read More

AARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.

AARDEX is proud to announce the integration of its MEMS® Adherence Software by a major pharmaceutical company. It’s the first end-to-end integration of electronically compiled dosing histories using smart packages from interactive response technology (IRT) into electronical data capture systems … Read More